TSLA
Tesla, Inc.
TSLA's fundamentals are mixed, but it looks expensive: trading at 437x earnings, more than twice its usual 175x. Analysts expect earnings growth, though they disagree widely on how much.
ZKH
ZKH Group Limited
There isn't enough reported data to score ZKH yet.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
ZKH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Stable | |
| Unavailable |
ZKH's cash flow is currently stable, but its revenue and profitability are under pressure. There isn't enough data to rate its balance sheet.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
ZKH PE Valuation
ZKH has no meaningful PE right now: it lost money over the past year.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
ZKH Forward outlook
There aren't enough analyst estimates for ZKH to show an outlook.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA has the edge over ZKH in the latest year-over-year earnings comparison.
ZKH Earnings Per Share
ZKH is still losing money, but far less than before: $9.19 per share over the past year, against $165.30 at its worst in late 2021.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA has the edge over ZKH on profitability, with a higher operating margin.
ZKH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $365.7M | +12% |
| Q1 2026 | $317.2M | +9.2% |
| Q4 2025 | $383.8M | -70% |
| Q3 2025 | $349.4M | +2.1% |
| Q2 2025 | $325.2M | -3.7% |
| Q1 2025 | $290.4M | +4% |
| Q4 2024 | $1.3B | +245% |
| Q3 2024 | $342.3M | +0.7% |
ZKH has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 0.2% | +3.5 points |
| Q1 2026 | -1.1% | +3.1 points |
| Q4 2025 | -1.1% | +2.7 points |
| Q3 2025 | -1.4% | +3.2 points |
| Q2 2025 | -3.3% | -0.1 points |
| Q1 2025 | -4.2% | +2.8 points |
| Q4 2024 | -3.8% | -3.6 points |
| Q3 2024 | -4.6% | +0.7 points |
ZKH's operating margin was 0.2% last quarter, up 3.5 points from the same quarter a year ago, near the top of its range since 2020.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA has the edge over ZKH on cash flow, with more consistent year-over-year improvement.
ZKH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | +$12.5M |
| Q3 2024 | $0 | $0 |
ZKH's free cash flow was $0 over the past year, against $0 the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
ZKH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -59K shares |
| 1 year | -1.6% | -72.8K shares |
| 3 years | +386% | +3.7M shares |
ZKH has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has more cash than debt.
ZKH Net Leverage
ZKH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
ZKH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.8 | Oversold |
| Stochastic | 6.5 | Oversold |
ZKH's weekly RSI is 20 (oversold) and its Stochastic is 7 (oversold).
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
ZKH PE vs Consumer Cyclical Sector
ZKH has no meaningful PE right now: it lost money over the past year.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has stronger trend alignment. TSLA is above 5 of 5 weekly averages versus ZKH above 0 of 4.
ZKH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.91 | 33% below |
| 20 week MA | $2.48 | 48% below |
| 50 week MA | $2.88 | 56% below |
| 100 week MA | $3.02 | 58% below |
ZKH is in a downtrend: it's below all four of its weekly moving averages, and 58% below its 100-week average.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over ZKH on returns for 2026, with the stronger performance.
ZKH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $15.5 | $16.3 | +5.2% |
| 2024 | $16.3 | $3.35 | -79% |
| 2025 | $3.35 | $3.65 | +9% |
| 2026 YTD | $3.65 | $1.28 | -65% |
ZKH is down 65% so far in 2026, after finishing higher in two of the previous three years.